Avricore Health (AVCRF) EBIAT (2016 - 2025)
Avricore Health has reported EBIAT over the past 12 years, most recently at -$676276.2 for Q4 2025.
- Quarterly EBIAT fell 32.59% to -$676276.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.3 million through Dec 2025, down 180.48% year-over-year, with the annual reading at -$1.3 million for FY2025, 172.27% down from the prior year.
- EBIAT was -$676276.2 for Q4 2025 at Avricore Health, down from -$275603.9 in the prior quarter.
- Over five years, EBIAT peaked at $211592.0 in Q2 2023 and troughed at -$1.0 million in Q4 2022.
- The 5-year median for EBIAT is -$156156.1 (2021), against an average of -$207191.3.
- The largest YoY upside for EBIAT was 188.29% in 2024 against a maximum downside of 1265.4% in 2024.
- A 5-year view of EBIAT shows it stood at -$165723.9 in 2021, then crashed by 518.65% to -$1.0 million in 2022, then skyrocketed by 104.27% to $43766.6 in 2023, then tumbled by 1265.4% to -$510057.5 in 2024, then tumbled by 32.59% to -$676276.2 in 2025.
- Per Business Quant, the three most recent readings for AVCRF's EBIAT are -$676276.2 (Q4 2025), -$275603.9 (Q3 2025), and -$331271.8 (Q2 2025).